Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,451Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/novartis-asciminib-bests-pfizer-s-bosulif-phase-3-leukemia-trial

Nick P.Taylor FIERCE BIOTECH
27 Aug 2020

https://www.raps.org/news-and-articles/news-articles/2018/2/ema%E2%80%99s-chmp-recommends-five-new-medicines-for-appro?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=k7BK4

Ana Mulero RAPS
26 Feb 2018
First-line use of Pfizer’s Bosulif cleared in the US
First-line use of Pfizer’s Bosulif cleared in the US

21 Dec 2017

// Selina McKee PHARMA TIMES

http://www.pharmatimes.com/news/first-line_use_of_pfizers_bosulif_cleared_in_the_us_1214830

Selina McKee PHARMA TIMES
21 Dec 2017
Pfizer, Avillion file for Bosulif expansion
Pfizer, Avillion file for Bosulif expansion

31 Aug 2017

// Selina McKee PHARMA TIMES

http://www.pharmatimes.com/news/pfizer,_avillion_file_for_bosulif_expansion_1203702

Selina McKee PHARMA TIMES
31 Aug 2017
Pfizer's Ibrance faces tough review at NICE, U.K. exec worries
Pfizer's Ibrance faces tough review at NICE, U.K. exec worries

28 Nov 2016

// Eric Sagonowsky FIERCE PHARMA

http://www.fiercepharma.com/pharma/pfizer-s-ibrance-combo-faces-tough-review-at-nice-exec-worries

Eric Sagonowsky FIERCE PHARMA
28 Nov 2016

http://www.reuters.com/article/us-health-cancer-britain-idUSKBN12Y004

Ben Hirschler REUTERS
03 Nov 2016